[Federal Register Volume 59, Number 164 (Thursday, August 25, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-20909]
[[Page Unknown]]
[Federal Register: August 25, 1994]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Announcement 405]
Grants for Injury Control Research Centers; Notice Availability
Of Funds for Fiscal Year 1995
Introduction
The Centers for Disease Control and Prevention (CDC) announces
that grant applications are being accepted for Injury Control
Research Centers (ICRC's). The Public Health Service (PHS) is
committed to achieving the health promotion and disease prevention
objectives of ``Healthy People 2000,'' a PHS-led national activity
to reduce morbidity and mortality and improve the quality of life.
This announcement is related to the priority areas of Violent and
Abusive Behavior and Unintentional Injuries. For ordering a copy of
``Healthy People 2000,'' see the Section ``Where to Obtain
Additional Information.''
Authority
This program is authorized under Sections 301 and 391-394 of the
Public Health Service Act (42 U.S.C. 241 and 280b-280b-3). Program
regulations are set forth in 42 CFR, Part 52.
Smoke-Free Workplace
The Public Health Service strongly encourages all grant
recipients to provide a smoke-free workplace and promote the non-use
of all tobacco products. This is consistent with the PHS mission to
protect and advance the physical and mental health of the American
people.
Eligible Applicants
Eligible applicants include all nonprofit and for-profit
organizations. Thus, universities, colleges, research institutions,
hospitals, other public and private organizations, State and local
health departments, and small, minority and/or women-owned
businesses are eligible for these grants. Applicants from non-
academic institutions should provide evidence of a collaborative
relationship with an academic institution. Current recipients of CDC
injury control research center grants and injury control research
program project grants are eligible to apply.
Availability of Funds
Approximately $1,500,000 is expected to be available in fiscal
year (FY) 1995 to fund approximately one new or re-competing center
award. (A portion of this amount may be allocated to support
currently approved but unfunded phases of newly funded ICRCs.) New
awards can be made for a project period not to exceed three years,
and re-competing awards can be made for a project period not to
exceed five years. The amount of funding available may vary and is
subject to change. Beginning award dates for each submission are
shown in the ``Receipt and Review Schedule'' section of this
announcement. Continuation awards within the project period will be
made on the basis of satisfactory progress and the availability of
funds.
New center grant awards will not exceed $500,000 per year (total
of direct and indirect costs) with a project period not to exceed
three years. Depending on availability of funds, re-competing
existing center awards may range from $750,000 to $1,500,000 per
year (total of direct and indirect costs) with a project period not
to exceed five years. The range of support provided is dependent
upon the degree of comprehensiveness of the center in addressing the
phases of injury control (i.e., Prevention, Acute Care, and
Rehabilitation) as determined by the Injury Research Grants Review
Committee (IRGRC).
Incremental levels within this range for successfully
recompeting ICRC's will be determined as follows:
Base funding (included in figures below): Up to $750,000
One phase ICRC (addresses one of the three phases of injury control):
Up to $1,000,000
Two phase ICRC (addresses two of the three phases of injury control):
Up to $1,250,000
Comprehensive ICRC (addresses all three phases of injury control): Up
to $1,500,000
Subject to program needs and the availability of funds,
supplemental awards to expand/enhance existing projects, to add a
new phase(s) to an existing ICRC grant, or to add biomechanics
project(s) that support phases may be made for up to $250,000 per
year.
Purpose
The purposes of this program are:
A. To support injury prevention and control research on priority
issues as delineated in: Healthy People 2000; Injury Control in the
1990's: A National Plan for Action; Injury in America; Injury
Prevention: Meeting the Challenge; and Cost of Injury: A Report to
the Congress. Information on these reports may be obtained from the
individuals listed in the section ``Where to Obtain Additional
Information'';
B. To support ICRC's which represent CDC's largest national
extramural investment in injury control research and training,
intervention development, and evaluation;
C. To integrate collectively, in the context of a national
program, the disciplines of engineering, epidemiology, medicine,
biostatistics, public health, law and criminal justice, and
behavioral and social sciences, in order to prevent and control
injuries more effectively;
D. To identify and evaluate current and new interventions for
the prevention and control of injuries;
E. To bring the knowledge and expertise of ICRC's to bear on the
development and improvement of effective public and private sector
programs for injury prevention and control; and
F. To facilitate injury control efforts supported by various
governmental agencies within a geographic region.
Program Requirements
A. Applicants must demonstrate and apply expertise in at least
one of the three phases of injury control (prevention, acute care,
or rehabilitation) as a core component of the center. The second
and/or third phases do not have to be supported by core funding but
may be achieved through collaborative arrangements. Comprehensive
ICRC's must have all three phases supported by core funding.
B. Applicants must document ongoing injury-related research
projects or control activities currently supported by other sources
of funding.
C. Applicants must provide a director (Principal Investigator)
who has specific authority and responsibility to carry out the
project. The director must report to an appropriate institutional
official, e.g., dean of a school, vice president of a university, or
commissioner of health. The director must have no less than 30
percent effort devoted solely to this project with an anticipated
range of 30 to 50 percent.
D. Applicants must demonstrate experience in successfully
conducting, evaluating, and publishing injury research and/or
designing, implementing, and evaluating injury control programs.
E. Applicants must provide evidence of working relationships
with outside agencies and other entities which will allow for
implementation of any proposed intervention activities.
F. Applicants must provide evidence of involvement of
specialists or experts in medicine, engineering, epidemiology, law
and criminal justice, behavioral and social sciences, biostatistics,
and/or public health as needed to complete the plans of the center.
These are considered the disciplines and fields for ICRC's. An ICRC
is encouraged to involve biomechanicists in its research. This,
again, may be achieved through collaborative relationships as it is
no longer a requirement that all ICRC's have biomechanical
engineering expertise.
G. Applicants must have an established curricula and graduate
training programs in disciplines relevant to injury control (e.g.,
epidemiology, biomechanics, safety engineering, traffic safety,
behavioral sciences, or economics).
H. Applicants must demonstrate the ability to disseminate injury
control research findings, translate them into interventions, and
evaluate their effectiveness.
I. Applicants must have an established relationship,
demonstrated by letters of agreement, with injury prevention and
control programs or injury surveillance programs being carried out
in the State or region in which the ICRC is located. Cooperation
with private-sector programs is encouraged.
Applicants should have an established or documented planned
relationship with organizations or individual leaders in communities
where injuries occur at high rates, e.g., minority health
communities.
Grant funds will not be made available to support the provision
of direct care. Studies may be supported which evaluate methods of
care and rehabilitation for potential reductions in injury effects
and costs. Studies can be supported which identify the effect on
injury outcomes and cost of systems for pre-hospital, hospital, and
rehabilitative care and independent living.
Eligible applicants may enter into contracts, including
consortia agreements (as set forth in the PHS Grants Policy
Statement, dated April 1, 1994), as necessary to meet the
requirements of the program and strengthen the overall application.
Evaluation Criteria
Upon receipt, applications will be reviewed by CDC staff for
completeness and responsiveness as outlined under the previous
heading ``Program Requirements.'' (A listing of where these
requirements are described and/or documented in the application will
facilitate the review process.) Incomplete applications and
applications that are not responsive will be returned to the
applicant without further consideration.
Applications which are complete and responsive may be subjected to
a preliminary evaluation by reviewers from the Injury Research Grants
Review Committee (IRGRC) to determine if the application is of
sufficient technical and scientific merit to warrant further review;
the CDC will withdraw from further consideration applications judged to
be noncompetitive and promptly notify the principal investigator/
program director and the official signing for the applicant
organization.
Those applications judged to be competitive will be further
evaluated by a dual review process. The primary review will be a peer
evaluation (IRGRC) of the scientific and technical merit of the
application. The final review will be conducted by the CDC Advisory
Committee for Injury Prevention and Control (ACIPC), which will
consider the results of the peer review together with program need and
relevance. Funding decisions will be made by the Director, National
Center for Injury Prevention and Control (NCIPC), based on merit and
priority score ranking by the IRGRC, program review by the ACIPC, and
the availability of funds.
A. Review by the Injury Research Grants Review Committee (IRGRC)
Peer review of ICRC grant applications will be conducted by the
IRGRC, which may recommend the application for further consideration or
not for further consideration. Site visits will be a part of this
process for recompeting ICRC's. Reverse site visits may be a part of
this process for new applicants.
Factors to be considered by IRGRC include:
1. The specific aims of the application, e.g., the long-term
objectives and intended accomplishments.
2. The scientific and technical merit of the overall application,
including the significance and originality (e.g., new topic, new
method, new approach in a new population, or advancing understanding of
the problem) of the proposed research.
3. The extent to which the evaluation plan will allow for the
measurement of progress toward the achievement of stated objectives.
4. Qualifications, adequacy, and appropriateness of personnel to
accomplish the proposed activities.
5. The soundness of the proposed budget in terms of adequacy of
resources and their allocation.
6. The appropriateness (e.g., responsiveness, quality, and
quantity) of consultation, technical assistance, and training in
identifying, implementing, and/or evaluating intervention/control
measures that will be provided to public and private agencies and
institutions, with emphasis on State and local health departments, as
evidenced by letters detailing the nature and extent of this commitment
and collaboration. Specific letters of support or understanding from
appropriate governmental bodies must be provided.
7. Evidence of other public and private financial support.
8. Progress thus far made as detailed in the application if the
applicant is submitting a competitive renewal application. Documented
success examples include: development of pilot projects; completion of
high quality research projects; publication of findings in peer
reviewed scientific and technical journals; number of professionals
trained; provision of consultation and technical assistance;
integration of disciplines; translation of research into
implementation; impact on injury control outcomes including
legislation/regulation, treatment, and behavior modification
interventions.
B. Review by CDC Advisory Committee for Injury Prevention and Control
(ACIPC)
Factors to be considered by ACIPC include:
1. The results of the peer review.
2. The significance of the proposed activities as they relate to
national program priorities and the achievement of national objectives.
3. National and programmatic needs and geographic balance.
4. Overall distribution of the thematic focus of competing
applications; the nationally comprehensive balance of the program in
addressing; the three phases of injury control (prevention, acute care,
and rehabilitation); the control of injury among populations who are at
increased risk, including minority groups, the elderly and children;
the major causes of intentional and unintentional injury; and the major
disciplines of injury control (such as biomechanics and epidemiology).
5. Within budgetary considerations the ACIPC will establish annual
funding levels as detailed under the heading ``Availability of Funds.''
C. Applications for Supplemental Funding
Supplemental grant awards may be made when funds are available to
support research work or activities. Applications should be clearly
labeled to denote their status as requesting supplemental funding
support. These applications will be reviewed by the IRGRC and the
ACIPC.
D. Continued Funding
Continuation awards within the project period will be made on the
basis of the availability of funds and the following criteria:
1. The accomplishments of the current budget period show that the
applicant's objectives as prescribed in the yearly workplans are being
met;
2. The objectives for the new budget period are realistic,
specific, and measurable;
3. The methods described will clearly lead to achievement of these
objectives;
4. The evaluation plan allows management to monitor whether the
methods are effective by having clearly defined process, impact, and
outcome objectives, and the applicant demonstrates progress in
implementing the evaluation plan;
5. The budget request is clearly explained, adequately justified,
reasonable, and consistent with the intended use of grant funds; and
6. Progress has been made in developing cooperative and
collaborative relationships with injury surveillance and control
programs implemented by State and local governments and private sector
organizations.
Award Priorities
Special consideration will be given to re-competing Injury Control
Research Centers.
Executive Order 12372
Applications are not subject to the review requirements of
Executive Order 12372, entitled Inter-Governmental Review of Federal
Programs.
Public Health System Reporting Requirements
This program is not subject to the Public Health System Reporting
Requirement.
Catalog of Federal Domestic Assistance Number
The Catalog of Federal Domestic Assistance Number is 93.136.
Application Submission and Deadlines
A. Preapplication Letter of Intent
In order to schedule and conduct site visits as part of the formal
review process, potential applicants are encouraged to submit a
nonbinding letter of intent to apply to the Grants Management Officer
(whose address is given in this section, Item B). It should be
postmarked no later than one month prior to the submission deadline
(September 24, 1994, for October 24, 1994, submission deadline). The
letter should identify the relevant announcement number for the
response, indicate the submission deadline which will be met, name the
principal investigator, and specify the injury control theme or
emphasis of the proposed center (e.g., acute care, biomechanics,
epidemiology, prevention, intentional injury, or rehabilitation). The
letter of intent does not influence review or funding decisions, but it
will enable CDC to plan the review more efficiently.
B. Applications
Applicants should use Form PHS-398 (Rev. 9/91) and adhere to the
ERRATA Instruction Sheet for PHS-398 contained in the Grant Application
Kit. The narrative section for each project within an ICRC should not
exceed 25 typewritten pages. Refer to section 4, page 10, of PHS-398
instructions for font type and size. Applications not adhering to these
specifications may be returned to applicant. Applicants should submit
an original and five copies to Henry S. Cassell, III, Grants Management
Officer, Grants Management Branch, Procurement and Grants Office,
Centers for Disease Control and Prevention (CDC), 255 East Paces Ferry
Road, NE., Room 300, Mailstop E-13, Atlanta, Georgia 30305.
C. Deadlines
Applications shall be considered as meeting the deadline above if
they are either:
1. Received on or before the deadline date; or
2. Sent on or before the deadline date and received in time for
submission to the peer review committee. Applicants should request a
legibly dated U.S. Postal Service postmark or obtain a legibly dated
receipt from a commercial carrier or the U.S. Postal Service. Private
metered postmarks shall not be acceptable as proof of timely mailing.
Applications which do not meet the criteria in C.1. or C.2. above
are considered late applications and will be returned to the applicant.
Supplemental materials received later than thirty days after the
application receipt date are considered late and will be returned to
the applicant.
D. Receipt and Review Schedule
This is a continuous announcement. Consequently, these receipt
dates will be ongoing until further notice. The proposed timetables for
receiving applications and awarding grants are as follows:
----------------------------------------------------------------------------------------------------------------
Receipt of new/revised/supplementary/
competitive renewal applications Initial review Secondary review Earliest award date
----------------------------------------------------------------------------------------------------------------
October 24, 1994.............................. January............. March............... September 1, 1995.
----------------------------------------------------------------------------------------------------------------
Future receipt dates are as follows:
----------------------------------------------------------------------------------------------------------------
Receipt of new/revised/supplementary/
competitive renewal applications Initial review Secondary review Earliest award date
----------------------------------------------------------------------------------------------------------------
October....................................... January............. March............... September.
----------------------------------------------------------------------------------------------------------------
Where to Obtain Additional Information
To receive additional written information call (404) 332-4561. You
will be asked to leave your name, address, and phone number and will
need to refer to Announcement Number 405. You will receive a complete
program description, information on application procedures, and
application forms.
If you have questions after reviewing the contents of all the
documents, business management technical assistance may be obtained
from Maggie Slay, Grants Management Specialist, Centers For Disease
Control and Prevention (CDC), 255 East Paces Ferry Road, NE., MS-E13,
Atlanta, Georgia 30305, telephone (404) 842-6797. Programmatic
technical assistance may be obtained from Tom Voglesonger, Program
Manager, Injury Control Research Centers, National Center for Injury
Prevention and Control, Centers for Disease Control and Prevention
(CDC), 4770 Buford Highway, MS-K58, Atlanta, Georgia 30341-3724,
telephone (404) 488-4265.
Potential applicants may obtain a copy of ``Healthy People 2000''
(Full Report; Stock No. 017-001-00474-0) or ``Healthy People 2000''
(Summary Report; Stock No. 017-001-00473-1) through the Superintendent
of Documents, Government Printing Office, Washington, DC 20402-9325,
telephone (202) 783-3238.
Dated: August 17, 1994.
Joseph R. Carter,
Acting Associate Director for Management and Operations, Centers for
Disease Control and Prevention (CDC).
[FR Doc. 94-20909 Filed 8-24-94; 8:45 am]
BILLING CODE 4163-18-P
